SCHEMBL14218696

SCHEMBL14218696

CCN1CCCC(CN(C)C)C1

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
CCR2 P41597 3/20 0.34
KCNH2 Q12809 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CHRM5 P08912 1/20 0.33
ADRA2C P18825 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10238597 0.88 SMN1; SMN2 (0.34)
SCHEMBL18542759 0.85 DRD2 (0.45) DRD2DRD3BCHE
SCHEMBL12718204 0.79 BCHE (0.40) DRD2DRD3BCHECCR2KCNH2
SCHEMBL17286011 0.79 HRH3 (0.39) DRD3KCNH2CHRM5
SCHEMBL12718219 0.79 BCHE (0.40) DRD2DRD3BCHECCR2KCNH2
SCHEMBL17285991 0.79 HRH3 (0.39) DRD3KCNH2CHRM5
SCHEMBL9926453 0.79 BCHE (0.40) DRD2DRD3BCHECCR2KCNH2
SCHEMBL7853848 0.79 HRH3 (0.39) DRD3KCNH2CHRM5
SCHEMBL14685536 0.79
SCHEMBL4014571 0.79 ADORA2A (0.33) BCHEACHEMEN1KMT2AKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378411-B2 Substituted thienopyrimidinones as a mitotic kinesin inhibitor MERCK & CO., INC. (US) 2008-05-27 US disclosed
US-7262186-B2 Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor MERCK & CO., INC. (US) 2007-08-28 US disclosed
US-7262187-B2 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor MERCK & CO., INC. (US) 2007-08-28 US disclosed
US-7244723-B2 Substituted furopyrimidinones as a mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-07-17 US disclosed